Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of fluorinated active pharmaceutical ingredients (APIs). Its structure supports the introduction of fluorine-containing aromatic moieties into larger drug molecules, enhancing metabolic stability and bioavailability. Commonly employed in the preparation of anti-inflammatory and central nervous system agents. Also utilized in research settings for the construction of chiral building blocks via asymmetric synthesis.